Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Phibro Animal Health Corporation Reports Third Quarter
May 11, 2015 4:45 PM EDTTEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced its financial results for its third quarter ended March 31, 2015.
Highlights for the March 2015 quarter (compared to the March 2014 quarter) Net sales of $187 million, an increase of 8% Adjusted EBITDA of $27.5 million, an increase of 23% Adjusted diluted EPS of $0.41COMMENTARY
Commenting on the quarter, Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer, said, "We are pleased with the development of our Animal Health and Mineral... More
Phibro Animal Health Corporation Reports Third Quarter
May 11, 2015 4:45 PM EDTTEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced its financial results for its third quarter ended March 31, 2015.
Highlights for the March 2015 quarter (compared to the March 2014 quarter) Net sales of $187 million, an increase of 8% Adjusted EBITDA of $27.5 million, an increase of 23% Adjusted diluted EPS of $0.41COMMENTARY
Commenting on the quarter, Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer, said, "We are pleased with the development of our Animal Health and Mineral... More
Phibro Animal Health Corporation Announces the Appointment of Dr. George Gunn to Its Board of Directors and Declares Quarterly Dividend
May 11, 2015 4:15 PM EDTTEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Dr. George Gunn as a Class III director of the company, effective immediately. Dr. Gunn will be an independent director. Dr. Gunn's appointment expands the Board to 8 directors, 5 of whom are independent directors. Dr. Gunn will also be a member of the company's Compensation Committee.
Dr. Gunn has over thirty years' experience in the animal health industry. Most recently, Dr. Gunn was the global head of Novartis AG's Animal Health... More
Phibro Animal Health Corporation Announces the Appointment of Dr. George Gunn to Its Board of Directors and Declares Quarterly Dividend
May 11, 2015 4:15 PM EDTTEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Dr. George Gunn as a Class III director of the company, effective immediately. Dr. Gunn will be an independent director. Dr. Gunn's appointment expands the Board to 8 directors, 5 of whom are independent directors. Dr. Gunn will also be a member of the company's Compensation Committee.
Dr. Gunn has over thirty years' experience in the animal health industry. Most recently, Dr. Gunn was the global head of Novartis AG's Animal Health... More
